PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Vertex Pharmaceuticals Incorporated (VRTX)

Equity · Currency in USD · Last updated Mar 2, 2024
SummaryFinancials

Company Info

ISINUS92532F1003
CUSIP92532F100
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$108.68B
EPS$13.87
PE Ratio30.33
PEG Ratio0.57
Revenue (TTM)$9.87B
Gross Profit (TTM)$5.32B
EBITDA (TTM)$4.48B
Year Range$283.60 - $448.40
Target Price$465.50
Short %1.60%
Short Ratio2.37

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Vertex Pharmaceuticals Incorporated, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


1,000.00%1,500.00%2,000.00%OctoberNovemberDecember2024FebruaryMarch
2,304.22%
1,256.72%
VRTX (Vertex Pharmaceuticals Incorporated)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with VRTX

Vertex Pharmaceuticals Incorporated

Popular comparisons: VRTX vs. LLY, VRTX vs. REGN, VRTX vs. SHEL, VRTX vs. XLE, VRTX vs. ABBV, VRTX vs. BX, VRTX vs. VTI, VRTX vs. VLO, VRTX vs. CRWD, VRTX vs. SCHD

Return

Vertex Pharmaceuticals Incorporated had a return of 6.36% year-to-date (YTD) and 48.84% in the last 12 months. Over the past 10 years, Vertex Pharmaceuticals Incorporated had an annualized return of 17.98%, outperforming the S&P 500 benchmark which had an annualized return of 10.63%.


PeriodReturnBenchmark
Year-To-Date6.36%7.70%
1 month-0.14%6.01%
6 months23.26%13.76%
1 year48.84%29.03%
5 years (annualized)17.64%12.89%
10 years (annualized)17.98%10.63%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20246.51%-2.92%
2023-1.14%-0.17%4.13%-2.02%14.68%

Risk-Adjusted Performance

This table presents risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
VRTX
Vertex Pharmaceuticals Incorporated
2.00
^GSPC
S&P 500
2.44

Sharpe Ratio

The current Vertex Pharmaceuticals Incorporated Sharpe ratio is 2.00. A Sharpe ratio higher than 2.0 is considered very good.


Rolling 12-month Sharpe Ratio0.501.001.502.002.50OctoberNovemberDecember2024FebruaryMarch
2.00
2.44
VRTX (Vertex Pharmaceuticals Incorporated)
Benchmark (^GSPC)

Dividend History


Vertex Pharmaceuticals Incorporated doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-15.00%-10.00%-5.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-2.99%
0
VRTX (Vertex Pharmaceuticals Incorporated)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Vertex Pharmaceuticals Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Vertex Pharmaceuticals Incorporated was 91.77%, occurring on Nov 11, 2003. Recovery took 2677 trading sessions.

The current Vertex Pharmaceuticals Incorporated drawdown is 2.99%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.77%Nov 3, 2000757Nov 11, 20032677Jul 2, 20143434
-81.22%Jul 25, 1991228Jun 18, 1992993May 23, 19961221
-70.19%Feb 25, 1997383Aug 31, 1998363Feb 8, 2000746
-55.25%Mar 7, 200029Apr 14, 200043Jun 16, 200072
-49.1%Aug 20, 2015340Dec 22, 2016142Jul 19, 2017482

Volatility Chart

The current Vertex Pharmaceuticals Incorporated volatility is 6.33%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%OctoberNovemberDecember2024FebruaryMarch
6.33%
3.47%
VRTX (Vertex Pharmaceuticals Incorporated)
Benchmark (^GSPC)